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It is a pleasure to answer and explain the three requests
mentioned in your letter to the editor [1]:1. OLetter to the Editorur study [2] should describe a practical tool not only
for diagnosis, but also for preoperative planning and
decision making of coronary bypass grafting. We adopted
and modified the classical segment model of the American
Heart Association. This coronary tree model is mainly
designed for diagnosis of any coronary disease from a
cardiologist’s perspective. We still used segments, but we
differentiated these sections more from a cardiac-surgical
perspective. Definitely, this is discussable; however, we
believe that we assess invasive coronary angiographies
(ICA) on different aspects compared with cardiologists. Of
course, thismodification is an individual classification from
our clinic and can also be used in a classical way. However,
it should demonstrate that it is timely and necessary to
assess imaging in the cardiac-surgical perspective, which
can differ from others because the goals are different.2. Of course, we used existing protocols, neither had we re-
programmed the software and/or developed new hard-
ware, nor have we changed the contents of the protocols
themselves. The modifications and new features were the
application and composition of soft- and hardware,
respectively, the different parts of the imaging tools
and techniques. In addition, the definition of arrange-
ments of responsibilities and manpower is important.
Radiologists are responsible for optimal image quality
for diagnostic, but cannot decide how many coronary
bypass grafts are necessary and where they should be
placed on the heart. This decision can only be done by
cardiac surgeons. Because of that, they have to be able to
use at least the basic steps at an original workstation to
define the strategy themselves. This cannot be done
based on images of radiologists because the purpose of
these images is different. Especially, cardiac surgeons
need three-dimensional (3D) images for overview of the
topography and orientation to plan a potential surgical
procedure, which is not possible in 2D images.3. We believe it is important to ‘keep it simple’, so that
transfer to clinical routine is easier to accomplish. The
quantification of degree of stenosis was performed in the
ICA in different views such as those commonly used in
clinical routine. The diameter measurements in comput-
ed tomography (CT) were performed with an electronic
calliper tool.
It is now the responsibility of cardiac surgeons to use CTas a
diagnostic and planning tool instead of ICA. Our article should
be an alert and encouragement to proceed. However, we also
realised the problem of a certain inhibition threshold. Cardiacsurgeons receive the prepared images by radiologists, which
are definitely not optimal to prepare surgery. On the other
hand, they do not have the time and practice to professionally
use the workstation of a CT scanner. Our article illustrates
one possibility to differentiate the work between radiologists
and cardiac surgeons. Cardiac surgeons should be at least
able to perform by themselves the steps which are described
in this article. Otherwise, it will not be possible to transfer
CT into clinical routine in the way it is desired and to replace
ICA, not only for exclusion diagnostic.
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AutoTissue GmbH as the manufacturer of the Matrix P
PlusW has some comments to the article of Ru¨ffer et al. [1].1. For production of the Matrix P Plus, only one patch is used
and not three as stated in the ‘Materials and Methods’
section.2. In the ‘Surgical Technique’ section, the authors described
their positioning of the valve as close to the bifurcation.
This is not in accordance with AutoTissue’s recommenda-
tions. It is suggested to place the valve like a homograft,
which means in a more or less orthotopic position.3. Selection of valve sizes is very problematic in this article.
Of the six explanted valves, one has been too small, three
were too large and only two valves in this cohort had the
appropriate size.4. Five out of six patients had stenoses at the distal
anastomosis. This has nothing to do with the tissue-
engineered valve but with the residual glutaraldehyde in
the equine patch, which envelopes the valve.5. The authors described ‘a’ dissection like ‘separation of
the layers between the internal and external conduit
membrane, which was still blood perfused during the
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between the valve and the patch will exit through the
holes into the pericardial space. Hopefully, during
surgery, the surgeons from Erlangen had not closed those
prefabricated holes in the patch.6. The histology shows the same pattern as with Contegra or
Shellhigh valves, which means fibro-proliferative tissue at
the level of the distal anastomosis. This is probably due to
residual glutaraldehyde in the patch material.7. The authors described that the outer patch remained cell-
free, which is actually impossible. The outer patch is
glutaraldehyde-fixed equine pericardium, which is not
cell-free, only the valve within the patch is cell-free. The
valve looked very nice at least in five out of the six cases,
as authors wrote in the article.8. The authors speculate about antigenicity. In fact,
AutoTissue could show that the tissue is non-antigenic
as there is no other antigenic material from porcine cell
membranes left in the de-cellularised tissue [2].9. The authors claim this to be the first publication regarding
short- and midterm results of the Matrix P PlusW. The
Matrix P PlusW came into the market in 2005; since then
approximately 30 publications, original publications and
abstracts, have been published in the surgical literature
(references on file at AutoTissue).
AutoTissue is alert to the problems arising from the use of
glutaraldehyde in its valved conduit and soon will bring out a
conduit totally free from glutaraldehyde.
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First, I would like to thank Dr Erdbru¨gger for his kind
invitation and his hospitality duringmy visit to AutoTissue andthe Charite´ Cardiovascular Surgery Department in Berlin. I
was able to observe the production of Matrix valves, including
their implantation during a Ross procedure.
Regarding his letter to the editor [1] as a reply to our word
of caution [2], I have a few comments:(1) The single patch forming the conduit wall of the
Matrix P plus has three segments: one enveloping
the valve and two outer ones for proximal and
distal anastomosis.(2) Our operative technique used for pulmonary valve
replacement in Ross procedures complies with the
Charite´ technique. Moreover, there is no ortho-
topic positioning possible in patients without right
ventricular outflow tract (RVOT), as in pulmonary
atresia or congenitally corrected transposition of
the great arteries with left ventricular insertion of
the conduit.(3) According to generally applied nomograms of
cardiac structures in relation to body size [3],
oversizing up to 0, 19, 9, 9, 9 and 8% (mean: 9  6%)
was present in the Matrix P plus failure group
(n = 6). There was certainly no undersizing! Sur-
prisingly, the group of patients without conduit
failure had oversizing in a higher degree (mean:
15  13%); however, this difference was statistical-
ly not significant (p = 0.65) [2].(4 and 6) We agree to the comments.
(5) The prefabricated holes were not closed by
surgery, but might have been blocked by the
clotting system. Blood flow in the wrong compart-
ment should not persist — if it does, it may be a
problem of conduit design.(7 and 8) The patch remained host-cell free. In all explanted
conduits, the porcine pulmonary artery wall was
covered by fibro-proliferative neo-intima contain-
ing inflammatory cells.(9) Until now, upon searching PubMed, no original
publications regarding clinical results with the
Matrix P plus for pulmonary valve replacement
have been found. We would be grateful to be
supplied with the published mid- and long-term
results from other institutions.References
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